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Mixed Germ Cell Tumor of the Pituitary-Hypothalamic 
Region Presenting as Craniopharyngioma: Case Report 
and Review of the Literature 
ABSTRACT
Craniopharyngiomas and germ cell tumors (GCT) may affect the pituitary-
hypothalamic region during childhood. Although different in origin, their 
clinical and radiological features may be similar. In this article we present a 
5-year-old girl with clinical and radiological fi ndings (computer tomography 
calcifi cation) that were initially considered as craniopharyngioma. However 
clinical outcome, blood and cerebral spinal fl uid tumoral markers, and results 
from anatomopathology and immunohistochemistry disclosed a mixed GCT. 
This case report highlights that some clinical features and radiological fi nd-
ings of pituitary-hypothalamic tumors may be misdiagnosed as craniophar-
yngioma mainly when there is a mature teratoma with cartilaginous tissue 
differentiation. (Arq Bras Endocrinol Metab 2008; 52/9:1501-1504)
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RESUMO
Tumor Misto de Células Germinativas da Região Hipotálamo-Hipofi sária Apre-
sentando-se como Craniofaringioma: Relato de Caso e Revisão da Literatura.
Craniofaringiomas e tumores mistos de células germinativas (TCG) podem 
acometer a região hipotálamo-hipofi sária durante a infância. Embora tenham 
diferentes origens, as manifestações clínicas e achados radiológicos podem 
ser semelhantes. Nosso objetivo é relatar o caso de uma paciente de 5 anos 
de idade, cujas manifestações clínicas e achados radiológicos (presença de 
calcifi cações à tomografi a computadorizada [TC]) foram inicialmente con-
siderados como provável craniofaringioma. No entanto, a piora clínica pro-
gressiva, marcadores tumorais séricos e liquóricos elevados, assim como os 
resultados do estudo anatomopatológico e imunoistoquímico revelaram tra-
tar-se de TCG. Este caso enfatiza que alguns achados clínicos e radiológicos 
de tumores da região hipotálamo-hipofi sária podem ser erroneamente diag-
nosticados como craniofaringiomas, principalmente se houver presença de 
teratoma maduro com diferenciação em tecido cartilaginoso. (Arq Bras Endo-
crinol Metab 2008; 52/9:1501-1504)
Descritores: Tumor de células germinativas; Craniofaringioma; Hipófi se; 
Hipotálamo
INTRODUCTION 
Primary germ cell tumors (GCT) of the central nervous system (CNS) are a rare and heterogeneous group of neoplasias with distinct histological 
subtypes. They are generally located in the midline and 40% involve the su-
prasellar region. Prevalence is higher in the early decades of life (1) where they 
comprise 0.5% to 3.0% of brain tumors (2). GCT may be classifi ed into germi-
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Figura 1. Sellar magnetic resonance imaging on coronal 
view showing a heterogeneous mass located in the sellar, su-
pra and infrasellar regions.
Ten days after admission, her clinical and neurologi-
cal status worsened (Glasgow Coma Scale=8/15) and 
she developed refractory hyperthermia without evidence 
of infectious disease. A brain CT revealed acute hydroce-
phalus. Due to the tumoral aggressive behavior and aty-
pical outcome the hypothesis of GCT was made and the 
following tumoral markers were evaluated. Seric human 
chorionic gonadotrophin (HCG-β) and alpha-fetopro-
tein (AFP) levels were, respectively, 1300 mIU/mL (re-
ference value RV < 5 mIU/mL) and 227 ng/mL (RV < 
7 ng/mL). On the cerebral spinal fl uid (CSF) (collected 
after surgery) the same tumoral markers, HCG-β and 
AFP, were 3802 ng/dL and 137 ng/mL, respectively 
(RV on the CFS=not detectable). 
She was without delay submitted to neurosurgery 
and partial resection of the tumor was performed. The 
anatomopathology and immunohistochemistry evalua-
tions showed mixed GCT with germinomatous com-
ponent, mature teratoma, and doubtful embryonal 
carcinoma component. After surgery she presented 
mild recovery from hyperthermia but remained in poor 
neurological condition. Chemotherapy with cisplatin, 
etoposide, and iphosphamide was initiated. She develo-
ped acute renal failure and bone marrow aplasia, and 
died 21 days after beginning chemotherapy. The pa-
tient relatives signed an informed consent allowing data 
publication.  
nomatous or nongerminomatous tumors. The former 
derive from primordial primitive cells corresponding to 
the most undifferentiated lineage and the latter origina-
tes from totipotent neoplastic germ cells, embryonal 
cells (teratoma or embryonal carcinoma) or non-em-
bryonal cell elements (endodermal sinus tumor and cho-
riocarcinoma) (3). Usually, tumors derived from the 
earlier stages of histogenesis (endodermal sinus tumor or 
choriocarcinoma) are more malignant than tumors from 
later stages (germinomas) (1,4,5). 
Craniopharyngiomas, on the other hand are be-
nign epithelial tumors of the CNS originating from 
embryonal remnants of Rathke’s pouch. Growth is in-
sidious mainly affecting the sellar and suprasellar re-
gions. They have two prevalence peaks, one in the fi rst 
two decades and another in the seventh and eighth de-
cades of life. Craniopharyngiomas make up 6% to 10% 
of all intracranial tumors and are the most prevalent in 
the pituitary-hypothalamic region of children (6). Al-
though usually benign, they may have an aggressive 
local behavior but rarely become malignant (7-9). 
In this article we report the case of a young girl 
with a mixed GCT of the pituitary-hypothalamic re-
gion that presented clinical and radiological features 
resembling craniopharyngioma.
SUBJECTS AND METHODS
Case Report
A 5-year-old girl was admitted with a 20-day history of 
headache, nausea, vomiting, and progressive visual fi eld 
loss. She also presented hyperphagia, polyuria, and 
polydipsia. On physical examination height and weight 
were at the 50th percentile and she was in prepubertal 
status. Neurological exam showed bilateral blindness. 
Endocrinological evaluation disclosed central hypo-
thyroidism, hypocortisolism, and diabetes insipidus. 
Despite lower IGF-1 levels (89ng/ml; Reference 
value=RV=242ng/ml – 2 standard deviations=50ng/
ml) the patient did not have stature defi cit. With the 
purpose to improve clinical outcome pre-surgical treat-
ment was initiated with hydrocortisone, levothyroxine, 
and desmopressin. Sellar magnetic resonance imaging 
(MRI) disclosed a heterogeneous mass located in the 
sellar, supra, and infrasellar regions (Figure 1), and a 
hyperintense area suggestive of intratumoral hemor-
rhage together with calcifi cations that were confi rmed 
in the sellar computer tomography (CT). 
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DISCUSSION
This case report highlights that some clinical features 
and radiological fi ndings of pituitary-hypothalamic tu-
mors may be misdiagnosed as craniopharyngioma. Fur-
thermore, sudden worsening of clinical and neurological 
status should draw attention to rapid tumor growth, 
which is not typical of craniopharyngiomas (6). In the-
se situations either the diagnosis of malignant change 
of craniopharyngioma or GCT should be postulated. 
Malignant change of craniopharyngiomas is rare 
and the mechanism of this process remains elusive (7-
9). Some authors propose that radiotherapy could be 
in part responsible (8), but since many patients are 
submitted to adjuvant radiotherapy without develo-
ping this complication, it is unlikely to be the main 
factor (10). 
Similar to craniopharyngiomas, GCT may also 
affect the suprasellar region during childhood (1,5,11-
13) leading to the same clinical manifestations. Nada 
and cols. (12) reported a similar case to ours in which a 
15-year-old boy presented visual impairment, diabetes 
insipidus and hypopituitarism. MRI was suggestive of a 
large suprasellar and retrosellar craniopharyngioma and 
histopathology of the fi rst surgical specimen was inter-
preted as craniopharyngioma. In a second histological 
examination, however, it was shown derivatives of all 
three germ cell lineages along with areas of embryonal 
carcinoma, and yolk sac tumor besides squamous cysts, 
establishing the diagnosis of malignant mixed germ cell 
tumor. Serum and CSF were strongly positive for AFP.
Moreover, craniopharyngiomas and GCT also sha-
re the same radiological features since mature terato-
mas may differentiate into cartilaginous tissue presenting 
on CT as a hyperdense lesion suggesting calcifi cation. 
Another relevant factor of the case aforementioned was 
the presence of a hemorrhagic area, which is rare not 
only in craniopharyngiomas but also in GCT tumors 
(14,15). Intratumoral hemorrhage of craniopharyn-
giomas tends to occur after over 15 years of tumor ma-
turation and the squamous-papillary type tend to bleed 
more than the adamantinomatous type (15).   
If serum or CSF tumoral markers are elevated 
(HCG-β and AFP), GCTs may be classifi ed as secreting 
tumors presenting a strong relationship to histological 
subtype (13,16) and generally have poor prognosis. 
In our case, after clinical worsening elevated HCG-β 
and AFP were important for the presurgical diagnosis 
of GCT. 
According to some authors biopsy is essential for 
GCT diagnosis (4,16). However, the small quantity of 
tumor specimen in mixed tumors may not be enough 
for the complete tumor characterization (17-20). In 
our case, surgical removal of the tumor was not suffi -
cient to provide its full characterization. In our opi-
nion the elevated levels of serum and CSF HCG-β 
could be explained by the presence of syncytiotropho-
blast secreting cells, or more probably, HCG-β secre-
ting choriocarcinoma that were not present in the 
specimen fragment. 
Treatment of GCT is still controversial and inclu-
des surgery, radio- and chemotherapy. Currently, 
combined therapy is the treatment of choice (1,4,17, 
20,21) due to tumor responsiveness to platinum-ba-
sed chemotherapies (22,23) and smaller doses of ra-
diotherapy (19,24).
Whether chemotherapy should be performed befo-
re or after neurosurgery is also controversial, except in 
urgent situations, such as in our case where the patient 
had sudden impairment of consciousness level due to 
acute hydrocephalus. Even with adjuvant platinum-ba-
sed chemotherapy our patient worsened her clinical 
and neurological status, not only due to tumor growth 
but also to side effects from chemotherapy (acute renal 
failure and bone marrow aplasia).
In conclusion, the clinical features and radiological 
fi ndings of pituitary-hypothalamic tumors may be simi-
lar in both craniopharyngioma and GCT. Despite redu-
ced mortality rates with the advent of chemotherapy, 
GCT is still considered as very aggressive and the che-
motherapy itself may cause serious complications. The-
refore, more studies with larger numbers of cases are 
needed to address these questions and determine the 
best treatment options for minimizing the side effects 
of adjuvant therapy and providing longer survival.
No potential confl ict of interest relevant to this article was 
reported.
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